Evolving Akoya Biosciences Touts CDx Partnerships at JP Morgan Conference
The Marlborough, Massachusetts-based firm also announced new panels for its PhenoCycler-Fusion and PhenoImager HT spatial analysis platforms.
Agilent, Akoya to Commercialize Workflow Tools for Tissue Biomarker Analysis
The end-to-end workflow products are intended for biopharmaceutical companies developing companion diagnostics for precision cancer therapeutics.
Akoya Biosciences, Acrivon Therapeutics Partner to Develop CDx
The companies will codevelop, validate, and commercialize a companion diagnostic for Acrivon's targeted DNA damage response inhibitor therapy, ACR-368.
Akoya Biosciences, Precision for Medicine to Develop Liquid Biopsy, Tissue Biomarker Tests
The team will combine Akoya's Vectra Polaris system with Precision for Medicine's Apostream tool to validate companion diagnostics and assess drug efficacy.